Skip to content
Search AI Powered

Latest Stories

India-made drugs dominate illegal imports in Switzerland

India-made drugs dominate illegal imports in Switzerland

A LARGE number of illegally imported drugs in Switzerland are found to have been sent from India, a Swiss government agency said on Monday (21).

They included medicines connected with Covid-19, ivermectin and hydroxychloroquine as also erectile stimulants.

In its annual update, the Swiss Agency for Therapeutic Products (Swissmedic) said it, along with customs authorities, seized 9,421 packages containing illegally imported medicinal products during 2021, which was significantly higher than 6,733 such packages in 2020.

The majority of the products seized were potency preparations and accounted for around 77 per cent of the confiscated packages.

Other preparations included prescription-only medicines, such as hormones and anti-inflammatories (17 per cent) or sleeping tablets and tranquillisers (five per cent).

Around 150 of the seized packages were connected with the Covid-19 pandemic. These contained prohibited quantities of prescription-only medicinal products, including anti-parasitics containing ivermectin, medicinal products containing hydroxychloroquine or antibiotics from India.

Swissmedic said Poland has overtaken south Asian nations to become the first European country to top the country-of-origin rankings.

However, the contents of the packages of potency preparations from Poland that were seized were all erectile stimulants manufactured in India.

Swissmedic suspects that new illegal distribution channels have been set up after the authorities successfully shut down the transit route via Singapore in October 2020 as part of an internationally coordinated operation.

India directly accounted for 12 per cent of total seized packages, down from 20 per cent in 2022 and from 43 per cent in 2019.

"Half of the illegally sold preparations do not contain what they claim to contain! Taking medicinal products that have been ordered without a prescription or with a sham online prescription is dangerous to health," Swissmedic said.

(PTI)

More For You

uk-rich-getty

Two men speak together as they cross over a footbridge in London's central business district of Canary Wharf. (Photo: Getty Images)

One millionaire leaves UK every 45 minutes, study finds

A RECORD number of millionaires have left the country since Labour took office, with concerns mounting over the party’s tax policies.

A study by New World Wealth and Henley & Partners revealed that Britain lost a net 10,800 millionaires in 2024, marking a 157 per cent rise from the previous year.

Keep ReadingShow less
UK to lead European growth in 2025, predicts IMF

FILE PHOTO: A view of the Bank of England and the financial district, in London, Britain. REUTERS/Mina Kim.

UK to lead European growth in 2025, predicts IMF

BRITAIN is set to have the fastest growth among major European economies this year, according to the International Monetary Fund, a boost to finance minister Rachel Reeves who is under pressure over a slowdown since her party came to power in July.

The IMF has raised its forecast for British growth for 2025 by 0.1 percentage points to 1.6 per cent, making it the third-strongest among the Group of Seven advanced economies after the US and Canada.

Keep ReadingShow less
Reliance Industries

Revenue from operations rose 6.97 per cent year-on-year to £22.99 bn, with growth seen across all divisions. (Photo: Reuters)

REUTERS

Reliance Industries reports 7.38 per cent rise in quarterly profit

RELIANCE INDUSTRIES reported a 7.38 per cent year-on-year increase in profit for the December quarter on Thursday, driven by growth in its consumer-focused divisions.

The company, led by Mukesh Ambani, remains India’s most valuable by market capitalisation.

Keep ReadingShow less
India faces growth challenge
as global uncertainty mounts

Narendra Modi (left) and Nirmala Sitaraman

India faces growth challenge as global uncertainty mounts

AFTER world-beating economic growth last year, India’s policymakers are scrambling to prevent a sharp slowdown as worsening global conditions and declining domestic confidence undo a recent stock market rally.

Last Tuesday (7), Asia’s third-largest economy forecast 6.4 per cent annual growth for the fiscal year ending in March, the slowest in four years and below initial projections, weighed down by weaker investment and manufacturing.

Keep ReadingShow less
Tata Consultancy sees 5.6 per cent rise in revenue despite market challenges

Chief executive and managing director of TCS K Krithivasan

Tata Consultancy sees 5.6 per cent rise in revenue despite market challenges

INDIAN IT giant Tata Consultancy Services (TCS) posted a 5.6 per cent on-year rise in revenue for the December quarter last Thursday (9), after lower earnings in its key North American market.

The leader of India’s $254 billion (£208.4bn) IT sector, TCS is the second-largest company in India by market capitalisation and earns over 80 per cent of its revenue from Western clients.

Keep ReadingShow less